
Recently, I was providing some training to a GlobalSubmit client and one of the participants asked me about an xml document that was present in a folder along with the sample eCTD that we use for training. The document was called “porp.xml”. I explained that GlobalSubmit’s VALIDATE product can transform eCTD into RPS and when it does, it produces the XML backbone used for RPS, which is called porp.xml. This is a single xml document that replaces eCTD’s index.xml, regional xml, and study tagging files.
The next question was “Why in the world is it called porp?” I couldn’t answer that one. But recently, I attended several training classes held by the font of all RPS knowledge, GlobalSubmit’s CTO Jason Rock. I took advantage of that opportunity to gain insight into what is different about RPS xml when compared to eCTD xml. [For the record, it’s called porp.xml because it had to be different than eCTD – and porp is a combination of po, the business domain within HL7, and rp for regulated product.]
But on to bigger topics. I, along with most other remotely technical people who have dabbled in eCTD for years, am pretty comfortable with eCTD xml. I can create the xml for a sequence by hand, and I can look at a sponsor’s xml and figure out what it represents and what is wrong with it. But when I look at the xml for RPS, all bets are off. Jason walked us through the xml in our training class and here are some of the observations that I made:
The bottom line is that RPS XML is only for the brave. Most of those intrepid souls creating XML by hand for eCTD will have to give up that practice, and everyone will need to ensure that they have a publishing vendor who is highly knowledgeable concerning the standard and who is able to produce very high quality software.
For those of you who would like to see what RPS xml looks like, check out Example RPS Code: BLA Multiple Sequence along with other Informational Documents (i.e. Plans, Rosters, RPS Technical Walkthrough, Implementation Guide, etc. on the RPS wiki.
At a GPhA/FDA Labeling Workshop on April 14, 2010, Virginia Ventura of CDER’s Office of Business Informatics presented CDER Update eCTD & Gateway Submissions. Along with lots of other useful information, Ms. Ventura provided an assessment of the current Top Processing Issues with Esubs:
|
Description |
Percent of total |
|
Unable to extract info from PDF form (sponsor did not use fillable form) |
52% |
|
Missing form (356h, 1571 or 2252) |
13% |
|
Bad Characters (per eCTD Spec) in file or folder names |
10% |
|
Duplicate sequence (sponsor sent twice) |
10% |
|
“High” validation errors |
7% |
|
Media empty or corrupted |
4% |
|
Wrong application number in us-regional.xml |
2% |
|
Invalid submission type identified (eCTD submitted as non-eCTD or vice versa) |
1% |
|
Valid application number with incorrect type (combination is valid but not Sponsor’s application) |
1% |
Certainly, the high percentage of submissions not using fillable forms is startling – Ms. Ventura mentioned that most of these are ANDAs. She spells out the solution for using 356h fillable forms (including their correct use with annual reports) – consult the presentation for details. She also stresses that the correct use of fillable forms results in your submission getting to the reviewer much quicker (best case an amazing 10 minutes!).
The amount of High Severity validation errors is also concerning, as the presentation reiterates what the FDA has said before - High Errors = Submission cannot be accepted. Therefore, up to 7% of these submissions may have been rejected, resulting in time off the PDUFA clock in many cases.
All of this serves as a wake-up call that validation and submission QC are more important than ever. Be sure to read the presentation for more tips on STFs, QC of us-regional.xml, use of the gateway, and many other quality issues and considerations.
This week’s blog posting is from Rahul Mistry, CEO of GlobalSubmit, who recently was a featured speaker at the RAPS workshop entitled “Advance eCTD Submissions”. Rahul’s presentation focused on eCTD quality, a topic that obviously interested the audience based on the significant number of questions that he received.
Two weeks ago I had the pleasure at presenting at an Advanced eCTD Workshop hosted by RAPS in Rockville, MD. During the course of three days, I had the pleasure of speaking and listening with a number of people from different companies. Here is what I learned: